News
Covid-19 Cord Blood TrialChannel 7 News have reported cord blood-derived cells are being used in a world first clinical trial to treat COVID-19.
Monash University and Monash Health are undertaking the trial for severe COVID-19 patients who are anticipated to improve within 24 hours of cord blood treatment.
COVID-19 and Cellular TherapyThe impact of COVID-19 is being felt worldwide and there is a tremendous amount of research being undertaken to understand this disease, prevent its transmission, and treat those infected. Patients with COVID-19 can present with little to no symptoms, cold or flu like symptoms, or in severe cases, can progress to pneumonia, sometimes leading to death.
COVID-19 UpdateAs the potential consequences of the coronavirus (COVID-19) are felt across many aspects of our lives, we’re reaching out to update our client families. We want to anticipate potential questions regarding the impact of the virus on cord blood collection, storage and therapeutic use.
You’ve nurtured and prepared your children to be happy and healthy adults. Now they’re grown up with children of their own arriving, there’s different, long lasting support you can provide.
There have been some exciting developments in a clinical trial investigating expanded cord blood for the treatment of blood cancers including leukemia.
Australian pre-clinical research has established through trials on mice that systematic administration of placental stem cells, after ischaemic stroke, stimulates significant neuroprotection and facilitates brain recovery and repair.
Children with various brain disorders who have their own or a sibling’s cord blood stored in a family bank may now be able to receive cord blood therapy regardless of whether they qualify for a targeted clinical trial...
This collaborative cord blood stem cell research will assist the determination of the safety and feasibility of injections of autologous umbilical cord blood stem cells into the right ventricle of children with Hypoplastic Left Heart Syndrome ...
Autism research using cord blood has been advanced in recent times by studies at Duke University, North Carolina and Shandong Jiaotong Hospital, China. With over 1 in 100 children in Australia diagnosed with autism...
Cord blood expansion focuses on the ability to expand the number of cells derived from a cord blood collection. An expanded cord blood unit can further boost utility in both current and future medical uses...
Prior to your child’s birth, there are a number of important decisions to make, including choosing what to do with their cord blood. There are essentially two stem cell storage options available to expectant parents…
A Duke University clinical trial has found the use of umbilical cord blood stem cells increases motor function and brain connectivity in children with cerebral palsy (CP).
October 2018 marked 30 years since Matthew Farrow, a 5-year old boy with Fanconi anemia received treatment using his newborn sister’s umbilical cord blood in the world’s first cord blood transplant. Since then, cord blood stem cells have been used…
Cell Care, Australia’s largest cord blood & tissue bank has announced it has acquired Insception Lifebank, Canada’s largest private cord blood & tissue bank. The combined entity creates one of the world’s top 10 companies in the sector.